Analyst Ratings for Vanda Pharmaceuticals (VNDA)
VNDA Rating Summary
VNDA Price Target Summary
- Highest: $20.00 (H.C. Wainwright)
- Lowest: $7.50 (Jefferies)
- Average: $13.08
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$13.08 (+224.6%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
Avg. $ Target:
$13.08 (+224.6%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/23/2026 | Oppenheimer | Les Sulewski | New Coverage | Outperform (N/A) |
10.00 (N/A) |
5.21 (4.03) |
-22.65% | Details |
| 3/5/2026 | Truist Securities » Updated 3/27/2026 |
Les Sulewski | New Coverage | Buy (N/A) |
18.00 (N/A) |
8.20 (4.03) |
-50.85% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
